ESR1 and cancer: Guajadial significantly reduces the proliferative effects of estrogen on estrogen-dependent cancer cells by reducing estradiol’s binding to estrogen receptors and blocking cell cycle progression, highlighting its promise as an effective therapy for these cancers [90].